Immune Thrombocytopenia News and Research

RSS
Massive clotting can destroy placenta and cause miscarriages

Massive clotting can destroy placenta and cause miscarriages

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Positive top-line results from alemtuzumab Phase 3 trial on multiple sclerosis

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

Symphogen's rozrolimupab Phase 2 data to be presented at European Hematology Association meeting

SuppreMol completes successful pre-IND meeting with U.S. FDA

SuppreMol completes successful pre-IND meeting with U.S. FDA

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Amgen to present data on Nplate studies for chronic ITP at ASH Annual Meeting

Nplate reduces treatment failure and splenectomies in adults with chronic immune thrombocytopenia

Nplate reduces treatment failure and splenectomies in adults with chronic immune thrombocytopenia

WinRho SDF for ITP: Cangene announces new safety information

WinRho SDF for ITP: Cangene announces new safety information

Amgen to present updated data on Nplate at the 2009 ASH meeting

Amgen to present updated data on Nplate at the 2009 ASH meeting